• Roche
  •  Overview
  • Last Modified:
  • July 31, 2025
  • Company type:
  • Public
  • Industry:
  • Pharmaceutical
  • Verified:
  • No
  • No of Employees:
  • 100 001 +
  • Stock Code:
  • ROG
  • Download
  • Signed Health Status Declaration Form
  • Turnover $50m + ?:
  • Yes
  • Headquarters:
  • Basel
  • Public Interest Score:
  • 750+

 

  • Roche
  • General Information

Description

Roche is a biotechnology company that develops drugs and diagnostics to treat major diseases. It provides medicines for the treatment of cancer, other auto-immune diseases, central nervous system disorders, ophthalmological disorders, infectious diseases, and respiratory diseases. The company also offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. Roche conducts research to identify novel methods to prevent, diagnose, and treat diseases. The company offers its products and services to hospitals, healthcare professionals, commercial laboratories, researchers, and pharmacists. Roche is headquartered in Basel, Switzerland.

Severin Schwan:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
André Hoffmann:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Jörg Duschmalé:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Patrick Frost:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Anita Hauser:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Akiko Iwasaki:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Richard Lifton:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Jemilah Mahmood:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Mark Schneider:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Claudia Dyckerhoff:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No

Subsribe/ Login to view details on company risk rating

Subscribe / Login

 

5 Benchmark > 4 Excellent > 3  Good > 2 Caution > 1 Risk

 

  • Company Information
  • Company System Number:
  • 15509
  • Founded Year: 
  • 1896
  • Registration Number: 
  • 01 09 872964
  • Country: 
  • Switzerland
  • Stock Exchanges: 
    • Swiss Stock Exchange
  • Financial year end: 
  • December
  • No. of Countries operations: 
  • 60
  • Company Status: 
  • In Business
  • Industry Sub Category: 
  • Healthcare
  • Date listed on Stock Exchange: 
  • 01/01/1979

 

  • Contact Information
  • Business operation: 
  • The Roche Group has a truly global spread of research, diagnostics and pharma development, data analytics and genomic insight teams at locations across 17 countries, spanning four continents, all working to translate science and research into ground-breaking therapies and diagnostics.
  • Primary office: 
  • Grenzacherstrasse 124, Basel, 4070

 

  • Additional Information
  • Listed?: 
  • Yes
  • Company secretary: 
  • Per-Olof Attinger
  • Reporting currency: 
  • CHF
  • ISIN number (12 digit): 
SWX
CH0012032113
  • Authorised shares:
  • Issued shares:
  • 6 378 000 000 000
  • No of shareholders:
  • 1001 and more shareholders
  • No of shareholders holding 20%:
  • 2 shareholders
  • Number of shares traded
  • Per Year:
  • Per Quarter:
  • Per Month:

 

Subscribe/ Login to view more details on Health Status 

Subscribe / Login

 

Shareholders holding 5% +


For a comprehensive list, please contact InsidEntity.

Material Subsidiaries/Associates


For a comprehensive list, please contact InsidEntity.

Credit Rating

NameLogoCountryHeadquartersRating
Moody's Financial ServicesCredit LogoUnited States of AmericaNew YorkAa2
S&P Global RatingsCredit LogoUnited States of AmericaNew YorkAA
Fitch RatingsCredit LogoUnited States of AmericaNew YorkAA

 

Countries Operations/ Offices


 

Company Directors

Name
Nationality
Age
Role
Qualification
Name

Severin

Non Executive
NationalityAustria
58
RoleChairman
QualificationMag. rer.soc.oec., Mag. iur., Dr. iur.
Date Appointed: 01/01/2023
Duration:
3 years and 2 months
Independance: Y
Profile
Name

André

Non Executive
NationalitySwitzerland
67
RoleVice Chairperson
QualificationMBA
Date Appointed: 01/01/2006
Duration:
20 years and 2 months
Independance: N
Profile
Name

Jörg

Non Executive
NationalitySwitzerland
42
RoleNED
QualificationB.S. Chem., MChem, Ph.D.
Date Appointed: 01/01/2020
Duration:
6 years and 2 months
Independance: Y
Profile
Name

Patrick

Non Executive
NationalitySwitzerland
58
RoleNED
QualificationDipl. Natw., lic. rer. pol., Dr. rer. pol., lic. iur.
Date Appointed: 01/01/2020
Duration:
6 years and 2 months
Independance: Y
Profile
Name

Anita

Non Executive
NationalitySwitzerland
57
RoleVice Chairperson
QualificationMBA, IDP
Date Appointed: 01/01/2017
Duration:
9 years and 2 months
Independance: Y
Profile
Name

Akiko

Non Executive
NationalityAmerican
56
RoleNED
QualificationB.Sc, Ph.D
Date Appointed: 01/01/2023
Duration:
3 years and 2 months
Independance: Y
Profile
Name

Richard

Non Executive
NationalityAmerican
73
RoleNED
QualificationBA., MD, PhD
Date Appointed: 01/01/2015
Duration:
11 years and 2 months
Independance: N
Profile
Name

Jemilah

Non Executive
NationalityMalaysia
67
RoleNED
QualificationM.D., IMD
Date Appointed: 01/01/2022
Duration:
4 years and 2 months
Independance: Y
Profile
Name

Mark

Executive
NationalityAmerican
61
RoleCEO
QualificationMBA, Ph.D. (Dr. oec.), Lic. oec.
Date Appointed: 01/01/2023
Duration:
3 years and 2 months
Independance: Y
Profile
Name

Claudia Süssmuth

Non Executive
NationalityGermany
59
RoleNED
QualificationPhD, MBA
Date Appointed: 01/01/2016
Duration:
10 years and 2 months
Independance: N
Profile

 

Directors Tenure

Name
Duration
Name

Severin Schwan

Duration3 years and 2 months
Profile
Name

André Hoffmann

Duration20 years and 2 months
Profile
Name

Jörg Duschmalé

Duration6 years and 2 months
Profile
Name

Patrick Frost

Duration6 years and 2 months
Profile
Name

Anita Hauser

Duration9 years and 2 months
Profile
Name

Akiko Iwasaki

Duration3 years and 2 months
Profile
Name

Richard Lifton

Duration11 years and 2 months
Profile
Name

Jemilah Mahmood

Duration4 years and 2 months
Profile
Name

Mark Schneider

Duration3 years and 2 months
Profile
Name

Claudia Süssmuth Dyckerhoff

Duration10 years and 2 months
Profile

 

Director Experience

Name
Experience
Name

Severin

Experience Pharmaceutical
Profile
Name

André

Experience Other
Profile
Name

Jörg

Experience Pharmaceutical
Profile
Name

Patrick

Experience Investment, Insurance
Profile
Name

Anita

Experience Education, Automobile
Profile
Name

Akiko

Experience Healthcare, Education
Profile
Name

Richard

Experience Healthcare, Education
Profile
Name

Jemilah

Experience Healthcare
Profile
Name

Mark

Experience Healthcare, Retail
Profile
Name

Claudia Süssmuth

Experience Healthcare, Retail
Profile

 

Company Auditors

Name
Date Appointed
Years
Name

KPMG

Date Appointed01/01/2017
Year9 years and 2 months
Profile

 

 

Company Committees

Name

Severin Schwan

Mainboard, Audit, Remuneration BD, NG
Profile
Name

André Hoffmann

Mainboard, Audit, Remuneration BD, RE, NG, OT
Profile
Name

Jörg Duschmalé

Mainboard, Audit, Remuneration BD, AU, RE
Profile
Name

Patrick Frost

Mainboard, Audit, Remuneration BD, AU
Profile
Name

Anita Hauser

Mainboard, Audit, Remuneration BD, RE, NG
Profile
Name

Akiko Iwasaki

Mainboard, Audit, Remuneration BD, OT
Profile
Name

Richard Lifton

Mainboard, Audit, Remuneration BD, RE
Profile
Name

Jemilah Mahmood

Mainboard, Audit, Remuneration BD, OT
Profile
Name

Mark Schneider

Mainboard, Audit, Remuneration BD, AU
Profile
Name

Claudia Süssmuth Dyckerhoff

Mainboard, Audit, Remuneration BD, AU, OT
Profile

 

Committee
Abbreviation
Supervisory Board
SB
Board
BD
Risk & Compliance
RC
Audit
AU
Remuneration
RE
Capital investment
CI
Industry Specific
IS
Nominations & Governance
NG
Health, Safety & Environment
HS
Social & Ethics
SE
Technology
TE
Executive
EX
Other
OT